KARISSA MISHLER: Open Payments
NPI 1235861386 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 7 payments from 4 companies in 2025. Trend: 2023 $1,584 · 2024 $813 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $142 |
| Alkermes, Inc. | 2 | $90 |
| E.R. Squibb & Sons, L.L.C. | 1 | $88 |
| Janssen Scientific Affairs, LLC | 1 | $57 |
Products named: Qelbree, COBENFY, LYBALVI, SPRAVATO, ARISTADA.
Industry payments across KS — which companies pay providers there.
